Inmed pharmaceuticals to report second quarter fiscal 2022 financial results and business update on february 15, 2022

Vancouver, british columbia, feb. 10, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, will report financial results on tuesday, february 15, 2022 for the second quarter of fiscal year 2022, ending december 31, 2021.
INM Ratings Summary
INM Quant Ranking